​Message from Medical Director NCCCR & Chair Corporate Cancer Services

It is a matter of great pleasure for me to welcome you all to the Second Qatar Molecular Imaging Nuclear Medicine Conference organized by the Molecular Imaging Nuclear Medicine Section (MINM), Hamad Medical Corporation along with Middle Eastern Federation of Medical Physics (MEFOMP), Society of Nuclear Medicine & Molecular Imaging (SNMMI) and the American Society of Nuclear Cardiology (ASNC) on 14 to 16 November 2023 at Intercontinental Doha Beach and Spa, Doha, Qatar.

Molecular Imaging Nuclear Medicine (MINM) plays a pivotal role in patient care, medical research, and pharmaceutical development and has been an integral part in Precision Medicine and personalized management of oncological and non-oncological disorders. Nuclear Medicine and Molecular Imaging Services in Hamad Medical Corporation started in the year 1983 with a Gamma Camera and has expanded to a wide range of services benefiting the population of Qatar.

 The 2nd Qatar Molecular Imaging Nuclear Medicine conference will witness a wide range of topics from conventional Nuclear Medicine to the recent advancements in the field including Artificial Intelligence with more than 20 international and nationally renowned speakers. This platform will provide an   opportunity for the professionals in this specialty for update and sharing their knowledge and to develop contacts and establish collaboration in the clinical, academic, and research areas.

I once again welcome you all to the vibrant city of Doha and wish for the grand success of the conference.

Dr. Mohamed Salem Jaber Al-Hassan
Medical Director NCCCR & Chair Corporate Cancer Services